DL-071-IT is primarily utilized in the field of pharmaceutical research, where it serves as a key compound in the development of therapeutic agents targeting neurological disorders. Its application is particularly significant in the study of neurodegenerative diseases, such as Alzheimer's and Parkinson's, due to its potential to modulate specific pathways involved in neuronal protection and repair. Researchers are exploring its efficacy in enhancing cognitive functions and mitigating the progression of neuronal damage. Additionally, DL-071-IT is being investigated for its role in improving synaptic plasticity, which is crucial for memory and learning processes. Its unique properties make it a promising candidate for the formulation of novel drugs aimed at addressing complex neurological conditions.